Literature DB >> 22986416

Reduced number of circulating endothelial progenitor cells (CD133+/KDR+) in patients with plaque psoriasis.

Aleksandra Batycka-Baran1, Maria Paprocka, Agnieszka Krawczenko, Aneta Kantor, Danuta Duś, Jacek C Szepietowski.   

Abstract

BACKGROUND: Psoriasis is associated with an increased cardiovascular risk. Circulating endothelial progenitor cells (CEPCs) play a significant role in the maintenance of vascular homeostasis.
OBJECTIVE: The aim of this study was to evaluate the number of CEPCs in patients with psoriasis compared to controls and assess possible correlations between the number of these cells and the plasma levels of vascular endothelial growth factor (VEGF), soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and clinical features of psoriasis.
METHODS: The number of CEPCs, identified as CD133+/KDR+ cells, was determined with flow cytometry in peripheral blood of psoriatic patients (n = 63) and controls (n = 31). The plasma levels of VEGF and sVEGFR-1 were measured with enzyme-linked immunosorbent assay.
RESULTS: The number of CEPCs was significantly reduced in psoriatic patients compared with controls (p = 0.000026) and inversely correlated with disease severity (R = -0.283; p = 0.0248).
CONCLUSION: A reduced number of CEPCs may contribute to endothelial dysfunction in patients with psoriasis.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986416     DOI: 10.1159/000341534

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  5 in total

Review 1.  Endothelial Dysfunction in Psoriasis: An Updated Review.

Authors:  Panagiota Anyfanti; Anastasia Margouta; Kyriakos Goulas; Maria Gavriilaki; Elizabeth Lazaridou; Aikaterini Patsatsi; Eugenia Gkaliagkousi
Journal:  Front Med (Lausanne)       Date:  2022-06-10

2.  Inhibiting the effect of (90)Sr-(90)Y ophthalmic applicators on rat corneal neovascularization induced by sutures.

Authors:  Hong-Yan Zhou; Shuang Wang; Hong Zhang; Ling Wang; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

3.  Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.

Authors:  Salim S Hayek; Robert Neuman; Nino Kavtaradze; Salman Sher; Dean Jones; Qunna Li; Liping Zhao; Suephy C Chen; Edmund Waller; Arshed Quyyumi
Journal:  Int J Cardiol       Date:  2014-12-27       Impact factor: 4.039

Review 4.  Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Magdalena Krajewska-Włodarczyk; Anna Kruszewska; Waldemar Placek; Wojciech Maksymowicz; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

Review 5.  Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.

Authors:  Dominik Samotij; Bogusław Nedoszytko; Joanna Bartosińska; Aleksandra Batycka-Baran; Rafał Czajkowski; Iwona T Dobrucki; Lawrence W Dobrucki; Magdalena Górecka-Sokołowska; Anna Janaszak-Jasienicka; Dorota Krasowska; Leszek Kalinowski; Marta Macieja-Stawczyk; Roman J Nowicki; Agnieszka Owczarczyk-Saczonek; Agata Płoska; Dorota Purzycka-Bohdan; Adrianna Radulska; Edyta Reszka; Anna Siekierzycka; Andrzej Słomiński; Radomir Słomiński; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz; Justyna Szczęch; Michał Żmijewski; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2020-05-05       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.